This page shows the latest Asthma UK news and features for those working in and with pharma, biotech and healthcare.
News from pharma, biotech and healthcare. Limited NICE approval for AZ’s asthma drug Fasenra. ... However, the UK's cost-effectiveness watchdog says the drug should only be used in limited circumstances for eosinophilic asthma, when usual therapies
The UK is welcoming a new set of national standards this coming year, which are designed to improve the quality and consistency of public involvement in research. ... The standards will be launched across ten pilot sites in the UK including Asthma UK
Teva's interleukin-5 (IL-5) inhibitor should be made available to patients under the NHS as an add-on therapy for patients with for severe eosinophilic asthma, says the ... Kay Boycott, chief executive of medical charity Asthma UK, welcomed the decision.
According to Asthma UK's Annual Asthma Survey 2016 report, emergency hospital admission is 23 times more expensive than an asthma review, with the annual cost of asthma care in the ... It is shocking that [according to Asthma UK's report] 82% of UK
A newly-agreed price cut and additional cost-effectiveness data prompt U-turn. Patients in the UK with severe asthma are on course to be able to receive treatment with ... There are thought to be around 100, 000 people in the UK who have uncontrolled
Teaming up with Asthma UK, the British Lung Foundation and independent medical research charity MRC Technology, AZ hopes to discover new epigenetic treatments for people living with respiratory diseases. ... The funding and support from Asthma UK and the
More from news
Approximately 3 fully matching, plus 17 partially matching documents found.
Prior to The NSMC, Patrick worked in the voluntary sector for ten years, initially in fundraising with Barnardos and VSO, and then at Asthma UK leading their Children and Young
Prior to The NSMC, Patrick worked in the voluntary sector for ten years, initially in fundraising with Barnardos and VSO, and then at Asthma UK leading their Children and Young
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...